A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD

Summary

The purpose of the study is to investigate the effect of fluticasone furoate/vilanterol Inhalation Powder on arterial stiffness compared with placebo and vilanterol over a 24-week treatment period in subjects with COPD and aortic pulse wave velocity of 11.0 m/s or above.

Timeline

Start

2011-03-04

Primary completion

2014-11-04

Completion

2014-11-04

Drugs

Indications